Metraipolis › archive › dc_ebc6a6d97053

Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments — Europe PMC PMID:42534456

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42534456
DOI
10.1093/ofid/ofag447
License (as archived)
solo-consultazione
Archived
2026-10-08T01:46:05.291Z
SHA-256 of the archived text
e8ca27046393810db1e3925c0c831d7612f6d291bf0f943e225b1f8b02b8e0fe
Stable URL of this page
https://metraipolis.com/documento/dc_ebc6a6d97053

How to cite

Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments — Europe PMC PMID:42534456 — Europe PMC (en), https://europepmc.org/article/MED/42534456 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebc6a6d97053 (Metraipolis archive dc_ebc6a6d97053, sha256 e8ca27046393810db1e3925c0c831d7612f6d291bf0f943e225b1f8b02b8e0fe)
BibTeX
@misc{dcebc6a6d97053,
  title = {Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments — Europe PMC PMID:42534456},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42534456},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebc6a6d97053; sha256 e8ca27046393810db1e3925c0c831d7612f6d291bf0f943e225b1f8b02b8e0fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42534456. Agents can read the archived copy with the MCP tool read_document.